Evogene Ltd.

The momentum for this stock is not very good. Evogene Ltd. is not a good growth stock. Evogene Ltd. is not very popular among insiders. Evogene Ltd. is a mediocre stock to choose.

Evogene Ltd. operates as a plant genomics company. It utilizes a proprietary integrated technology i...

News

Evogene (NASDAQ:EVGN) Receives New Coverage from Analysts at StockNews.com

Ticker Report StockNews.com began coverage on shares of Evogene (NASDAQ:EVGN - Free Report) in a research note released on Saturday. The brokerage issued a sell rating on the biotechnology company's stock...\n more…

Evogene (NASDAQ:EVGN) Coverage Initiated at StockNews.com

Zolmax StockNews.com started coverage on shares of Evogene (NASDAQ:EVGN - Free Report) in a report issued on Friday morning. The firm issued a sell rating on the biotechnology company's stock.\nSeparately...\n more…

StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN)

Ticker Report Equities researchers at StockNews.com started coverage on shares of Evogene (NASDAQ:EVGN - Get Free Report) in a note issued to investors on Friday. The brokerage set a "sell" rating on the...\n more…

Evogene (NASDAQ:EVGN) PT Lowered to $12.00 at Lake Street Capital

Zolmax Evogene (NASDAQ:EVGN - Free Report) had its price target trimmed by Lake Street Capital from $30.00 to $12.00 in a report issued on Friday, Benzinga reports. The firm currently has a buy rating on...\n more…

Evogene (NASDAQ:EVGN) Earns Sell Rating from Analysts at StockNews.com

Zolmax StockNews.com assumed coverage on shares of Evogene (NASDAQ:EVGN - Free Report) in a research report report published on Thursday. The brokerage issued a sell rating on the biotechnology company's...\n more…

Evogene (NASDAQ:EVGN) PT Lowered to $12.00

Zolmax Evogene (NASDAQ:EVGN - Get Free Report) had its price target decreased by analysts at Lake Street Capital from $30.00 to $12.00 in a note issued to investors on Friday, Benzinga reports. The...\n more…